Niedermeyer's Electroencephalography

2017 ◽  
Keyword(s):  
Premature Infants ◽  
Neurodegenerative Disorders ◽  
Head Injuries ◽  
Clinical Applications ◽  
Vast Number ◽  
Developmental Issues ◽  
On Line ◽  
Patients With Epilepsy ◽  
The Brain ◽  
Advanced Computer

This book deals with the field of Electroencephalography in the widest possible sense, from the cellular foundations of the electric activities of the brain to a vast number of clinical applications. The basic science sections were up-dated to include advanced computer modeling approaches. The chapters on normal and pathological EEG findings in premature infants, newborns and children were thoroughly revised to keep up with the advances that have taken place recently in studying brain developmental issues. Major advances have taken place in neurophysiological findings in a variety of neurodegenerative disorders, which led to thoroughly revised chapters. Other rapidly changing subjects related to EEG recording/monitoring in ICU's, EMUs, and operating rooms, in patients with epilepsy, head injuries, infectious disorders and those undergoing surgical procedures, led to radically updating a number of chapters and to the addition of a chapter dedicated to invasive recordings for the treatment of patients with movement disorders. A previously missing chapter on the neurophysiology of myoclonus was added. Chapters that deal with automated EEG interpretation techniques and with standardizing EEG reporting using ILAE/IFCN approved terminology, were also added. Many chapters in the on-line version of the book will have the ability to link to a database of over 150 complete EEGs that cover the scope seen in a general EEG Lab. This link will allow the reader to manipulate the EEG display parameters as if they were in their own lab, generate a report and compare it to one generated by a panel of senior EEGers.

Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies

2020 ◽  
Vol 26 (13) ◽  
pp. 1448-1465 ◽  
Author(s):  
Jozef Hanes ◽  
Eva Dobakova ◽  
Petra Majerova
Keyword(s):  
Drug Delivery ◽  
Blood Brain Barrier ◽  
Neurodegenerative Disorders ◽  
Brain Barrier ◽  
Neuronal Function ◽  
Brain Drug Delivery ◽  
Naturally Occurring ◽  
Blood Brain ◽  
Traditional Approaches ◽  
The Brain

Tauopathies are neurodegenerative disorders characterized by the deposition of abnormal tau protein in the brain. The application of potentially effective therapeutics for their successful treatment is hampered by the presence of a naturally occurring brain protection layer called the blood-brain barrier (BBB). BBB represents one of the biggest challenges in the development of therapeutics for central nervous system (CNS) disorders, where sufficient BBB penetration is inevitable. BBB is a heavily restricting barrier regulating the movement of molecules, ions, and cells between the blood and the CNS to secure proper neuronal function and protect the CNS from dangerous substances and processes. Yet, these natural functions possessed by BBB represent a great hurdle for brain drug delivery. This review is concentrated on summarizing the available methods and approaches for effective therapeutics’ delivery through the BBB to treat neurodegenerative disorders with a focus on tauopathies. It describes the traditional approaches but also new nanotechnology strategies emerging with advanced medical techniques. Their limitations and benefits are discussed.

Role of Flavonoids in Neurodegenerative Disorders with Special Emphasis on Tangeritin

2019 ◽  
Vol 18 (8) ◽  
pp. 581-597 ◽  
Author(s):  
Ambreen Fatima ◽  
Yasir Hasan Siddique
Keyword(s):  
Medicinal Plants ◽  
Mechanism Of Action ◽  
Neurodegenerative Disorders ◽  
Treatment Strategies ◽  
Dietary Supplementation ◽  
Plant Polyphenols ◽  
Promising Candidate ◽  
Naturally Occurring ◽  
The Brain

Flavonoids are naturally occurring plant polyphenols found universally in all fruits, vegetables and medicinal plants. They have emerged as a promising candidate in the formulation of treatment strategies for various neurodegenerative disorders. The use of flavonoid rich plant extracts and food in dietary supplementation have shown favourable outcomes. The present review describes the types, properties and metabolism of flavonoids. Neuroprotective role of various flavonoids and the possible mechanism of action in the brain against the neurodegeneration have been described in detail with special emphasis on the tangeritin.

scholarly journals Human Monocytes Plasticity in Neurodegeneration

Biomedicines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 717
Author(s):  
Ilenia Savinetti ◽  
Angela Papagna ◽  
Maria Foti
Keyword(s):  
Neurodegenerative Disorders ◽  
Current Knowledge ◽  
Neurological Diseases ◽  
Surface Marker ◽  
First Line ◽  
Surface Marker Expression ◽  
Physiological Properties ◽  
Attractive Therapeutic Target ◽  
The Brain ◽  
Lateral Sclerosis

Monocytes play a crucial role in immunity and tissue homeostasis. They constitute the first line of defense during the inflammatory process, playing a role in the pathogenesis and progression of diseases, making them an attractive therapeutic target. They are heterogeneous in morphology and surface marker expression, which suggest different molecular and physiological properties. Recent evidences have demonstrated their ability to enter the brain, and, as a consequence, their hypothetical role in different neurodegenerative diseases. In this review, we will discuss the current knowledge about the correlation between monocyte dysregulation in the brain and/or in the periphery and neurological diseases in humans. Here we will focus on the most common neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and multiple sclerosis.

scholarly journals A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies

2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Jie Zheng ◽  
Na Tian ◽  
Fei Liu ◽  
Yidian Zhang ◽  
Jingfen Su ◽  
...  
Keyword(s):  
Neurodegenerative Disorders ◽  
Protein Phosphatase ◽  
High Efficiency ◽  
Microtubule Assembly ◽  
Hyperphosphorylated Tau ◽  
Phosphatase 2A ◽  
Dependent Learning ◽  
The Brain

AbstractIntraneuronal accumulation of hyperphosphorylated tau is a hallmark pathology shown in over twenty neurodegenerative disorders, collectively termed as tauopathies, including the most common Alzheimer’s disease (AD). Therefore, selectively removing or reducing hyperphosphorylated tau is promising for therapies of AD and other tauopathies. Here, we designed and synthesized a novel DEPhosphorylation TArgeting Chimera (DEPTAC) to specifically facilitate the binding of tau to Bα-subunit-containing protein phosphatase 2A (PP2A-Bα), the most active tau phosphatase in the brain. The DEPTAC exhibited high efficiency in dephosphorylating tau at multiple AD-associated sites and preventing tau accumulation both in vitro and in vivo. Further studies revealed that DEPTAC significantly improved microtubule assembly, neurite plasticity, and hippocampus-dependent learning and memory in transgenic mice with inducible overexpression of truncated and neurotoxic human tau N368. Our data provide a strategy for selective removal of the hyperphosphorylated tau, which sheds new light for the targeted therapy of AD and related-tauopathies.

Detection of Intracranial Signatures of Interictal Epileptiform Discharges from Concurrent Scalp EEG

2016 ◽  
Vol 26 (04) ◽  
pp. 1650016 ◽  
Author(s):  
Loukianos Spyrou ◽  
David Martín-Lopez ◽  
Antonio Valentín ◽  
Gonzalo Alarcón ◽  
Saeid Sanei
Keyword(s):  
Detection Algorithm ◽  
The Other ◽  
Intracranial Eeg ◽  
Scalp Eeg ◽  
Epileptiform Discharges ◽  
Interictal Epileptiform Discharges ◽  
Scalp Electroencephalogram ◽  
Patients With Epilepsy ◽  
Electrical Activities ◽  
The Brain

Interictal epileptiform discharges (IEDs) are transient neural electrical activities that occur in the brain of patients with epilepsy. A problem with the inspection of IEDs from the scalp electroencephalogram (sEEG) is that for a subset of epileptic patients, there are no visually discernible IEDs on the scalp, rendering the above procedures ineffective, both for detection purposes and algorithm evaluation. On the other hand, intracranially placed electrodes yield a much higher incidence of visible IEDs as compared to concurrent scalp electrodes. In this work, we utilize concurrent scalp and intracranial EEG (iEEG) from a group of temporal lobe epilepsy (TLE) patients with low number of scalp-visible IEDs. The aim is to determine whether by considering the timing information of the IEDs from iEEG, the resulting concurrent sEEG contains enough information for the IEDs to be reliably distinguished from non-IED segments. We develop an automatic detection algorithm which is tested in a leave-subject-out fashion, where each test subject’s detection algorithm is based on the other patients’ data. The algorithm obtained a [Formula: see text] accuracy in recognizing scalp IED from non-IED segments with [Formula: see text] accuracy when trained and tested on the same subject. Also, it was able to identify nonscalp-visible IED events for most patients with a low number of false positive detections. Our results represent a proof of concept that IED information for TLE patients is contained in scalp EEG even if they are not visually identifiable and also that between subject differences in the IED topology and shape are small enough such that a generic algorithm can be used.

Event-Related Potentials in Psychiatry: Approaches to Research and Clinical Applications

1983 ◽  
Vol 17 (4) ◽  
pp. 307-318 ◽  
Author(s):  
H. G. Stampfer
Keyword(s):  
Information Processing ◽  
Psychiatric Disorders ◽  
Rapid Development ◽  
Event Related Potentials ◽  
Clinical Applications ◽  
Direct Access ◽  
Practical Application ◽  
Clinical Methods ◽  
Related Potentials ◽  
The Brain

This article suggests that the potential usefulness of event-related potentials in psychiatry has not been fully explored because of the limitations of various approaches to research adopted to date, and because the field is still undergoing rapid development. Newer approaches to data acquisition and methods of analysis, combined with closer co-operation between medical and physical scientists, will help to establish the practical application of these signals in psychiatric disorders and assist our understanding of psychophysiological information processing in the brain. Finally, it is suggested that psychiatrists should seek to understand these techniques and the data they generate, since they provide more direct access to measures of complex cerebral processes than current clinical methods.

Diagnosis as a Detriment: A Cognitive Approach to Understanding the Depressive Experience

2015 ◽  
Vol 17 (2) ◽  
pp. 125-134 ◽  
Author(s):  
Evan Hy Einstein
Keyword(s):  
Mental Health ◽  
Health Care ◽  
Theoretical Model ◽  
Mental Health Care ◽  
Cognitive Model ◽  
Clinical Applications ◽  
Psychotropic Medications ◽  
Cognitive Mechanisms ◽  
Cognitive Approach ◽  
The Brain

Depression is currently understood within a biomedical paradigm. This paradigm is an example of reductionism; people are clinically diagnosed and categorized based on behavior and affect, while they are then prescribed psychotropic medications based on an inconclusively correlated neurotransmitter imbalance in the brain. In this article, clinical diagnosis and labeling are explored with respect to their detrimental potential. A framework of embodied cognition is used to conceptualize a cognitive model of depressive experience. This theoretical model explores the potentially self-reinforcing cognitive mechanisms behind a depressive experience, with the goal of highlighting the possibility of diagnosis as a detrimental influence on these mechanisms. The aim of this article is to further a discussion about our current mental health care paradigm and provide an explanation as to how it could cause harm to some. Clinical applications of the model are also discussed pertaining to the potential of rendering formal dichotomist diagnoses irrelevant to the ultimate goal of helping people feel better.

scholarly journals A Review on Epilepsy and its Management

2020 ◽  
Vol 10 (3) ◽  
pp. 273-279
Author(s):  
V.V. Potnis ◽  
Ketan G. Albhar ◽  
Pritamsinh Arjun Nanaware ◽  
Vishal S. Pote
Keyword(s):  
Developing Countries ◽  
Neurological Disorders ◽  
Genetic Factors ◽  
Future Trends ◽  
Brain Infection ◽  
The World ◽  
Different Types ◽  
Patients With Epilepsy ◽  
The Brain

Today, people face various types of stress in everyday fast life and most people in the world suffer from various neurological disorder. Epilepsy is one of the most common neurological disorders of the brain, affecting about 50 million people around the world, and 90% of them are coming from developing countries. Genetic factors and brain infection, stroke, tumors and epilepsy cause high fever. It imposes a great economic burden on the health systems of countries associated with stigma and discrimination against the patient and also his family in the community, in the workplace, school and home. Many patients with epilepsy suffer from severe emotional stress, behavioral disorders and extreme social isolation. There are many different types of seizure and mechanisms by which the brain generates seizures. The two features of generating seizures are hyperexcitability of neurons and a hyper synchronousneural circuits. A variety of mechanisms alters the balance between excitation and inhibition in predisposing brain local or generalized hyperexcitability region and a hypersynchronia. Purpose of the review is to discuss the history, epidemiology, etiology, pathophysiology, classification of epilepsy, symtomps, diagnosis, management of epilepsy and future trends. Keywords: Anti-epileptic drugs, pathophysiology, seizures, epidemiology, hypersynchrony

Sign in / Sign up

Export Citation Format

Share Document